ADMINISTRATION SITE HYPERSENSITIVITY

ADMINISTRATION SITE HYPERSENSITIVITY was reported 31 times

ADMINISTRATION SITE HYPERSENSITIVITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phenylalanine Metabolizing Enzyme [EPC] 1 0.0001
1 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
2 GLP-2 Analog [EPC] 1 0.0001
3 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 1 0.0001
4 Human Immunoglobulin G [EPC] 1 0.0000
5 Prostacyclin Receptor Agonist [EPC] 1 0.0000
6 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
7 Prostacycline Vasodilator [EPC] 4 0.0000
8 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
9 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
10 Ester Local Anesthetic [EPC] 1 0.0000
11 Endothelin Receptor Antagonist [EPC] 4 0.0000
12 Non-Standardized Chemical Allergen [EPC] 1 0.0000
13 Amide Local Anesthetic [EPC] 1 0.0000
14 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
15 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
16 Antiarrhythmic [EPC] 1 0.0000
17 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
18 Parathyroid Hormone Analog [EPC] 1 0.0000
19 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
20 Aldosterone Antagonist [EPC] 1 0.0000
21 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
22 Microtubule Inhibitor [EPC] 1 0.0000
23 Expectorant [EPC] 1 0.0000
24 Platinum-based Drug [EPC] 1 0.0000
25 Factor Xa Inhibitor [EPC] 1 0.0000
26 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
27 Corticosteroid [EPC] 3 0.0000
28 Loop Diuretic [EPC] 1 0.0000
29 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000